Picture of Ion Beam Applications SA logo

IBAB — Ion Beam Applications SA News Story

0.000.00%
be flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

IBA drops to 34-month lows as H1 REBIT turns negative

** Shares in Ion Beam Applications  IBAB.BR  fall about 10%
after the company published its results in the first half, with
group REBIT turning to negative on backlog conversion miss
    ** The Belgian proton therapy company posts H1 REBIT loss of
20.3 million euros ($22.12 million) versus profit of 4.6 million
euros last year, which is affected by the backlog conversion
miss and preparation of growth investments for the next quarters
    ** The company also confirmed its FY guidance, expecting
strong improvement in H2
    ** KBC Securities says results are "well below" its
expectations
    ** "We think it will be difficult for IBA to reach our FY23
sales estimate of 456 million euros, meaning we will likely have
to revise our estimates", KBC Securities says
    ** The analysts from ING doubt the short term sentiment will
"prevail" over the brighter long term outlook, which is
"tainted" by macro fears
    ** Including Thursday's fall the stock has dropped by 26.61%
YTD, and shares are on track for its worst day since mid-March
2020
    ** The stock touches lowest price in about 34 months
    
($1 = 0.9179 euros)

 (Reporting by Lina Golovnya)
 ((lina.golovnya@thomsonreuters.com))

Recent news on Ion Beam Applications SA

See all news